Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma

This study is currently recruiting participants.

Verified April 2013 by National Cancer Institute (NCI)

Sponsor:

Information provided by (Responsible Party):

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT01055314

First received: January 22, 2010

Last updated: April 1, 2013

Last verified: April 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2016 (Final data collection date for primary outcome measure)